Boston Scientific (BSX) Accounts Payables (2009 - 2026)

Boston Scientific's Accounts Payables history runs 18 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Accounts Payables rose 13.65% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 13.65% YoY), while the FY2025 annual figure was $1.1 billion, up 19.17% from the prior year.
• Accounts Payables came in at $1.1 billion for Q1 2026 at Boston Scientific, roughly flat from $1.1 billion in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $1.1 billion in Q4 2025 to a low of $696.0 million in Q1 2022.
• A 5-year average of $922.2 million and a median of $921.0 million in 2024 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables gained 24.71% in 2023 and dropped 2.37% in 2024, its largest moves.
• Boston Scientific's Accounts Payables stood at $862.0 million in 2022, then rose by 9.28% to $942.0 million in 2023, then climbed by 1.91% to $960.0 million in 2024, then rose by 19.17% to $1.1 billion in 2025, then decreased by 0.26% to $1.1 billion in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $1.1 billion, $1.1 billion, and $1.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison